Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells
Therapies against hepatitis B virus (HBV) have improved in recent decades; however, the development of individualized treatments has been limited by the lack of individualized infection models. In this study, we used human induced pluripotent stem cell (hiPSC) to generate a functional liver organoid...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-09-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396418303001 |
id |
doaj-9fbe19a7a9ad4baeb5c9e965f22d7b12 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yun-Zhong Nie Yun-Wen Zheng Kei Miyakawa Soichiro Murata Ran-Ran Zhang Keisuke Sekine Yasuharu Ueno Takanori Takebe Takaji Wakita Akihide Ryo Hideki Taniguchi |
spellingShingle |
Yun-Zhong Nie Yun-Wen Zheng Kei Miyakawa Soichiro Murata Ran-Ran Zhang Keisuke Sekine Yasuharu Ueno Takanori Takebe Takaji Wakita Akihide Ryo Hideki Taniguchi Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells EBioMedicine |
author_facet |
Yun-Zhong Nie Yun-Wen Zheng Kei Miyakawa Soichiro Murata Ran-Ran Zhang Keisuke Sekine Yasuharu Ueno Takanori Takebe Takaji Wakita Akihide Ryo Hideki Taniguchi |
author_sort |
Yun-Zhong Nie |
title |
Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells |
title_short |
Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells |
title_full |
Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells |
title_fullStr |
Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells |
title_full_unstemmed |
Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells |
title_sort |
recapitulation of hepatitis b virus–host interactions in liver organoids from human induced pluripotent stem cells |
publisher |
Elsevier |
series |
EBioMedicine |
issn |
2352-3964 |
publishDate |
2018-09-01 |
description |
Therapies against hepatitis B virus (HBV) have improved in recent decades; however, the development of individualized treatments has been limited by the lack of individualized infection models. In this study, we used human induced pluripotent stem cell (hiPSC) to generate a functional liver organoid (LO) that inherited the genetic background of the donor, and evaluated its application in modeling HBV infection and exploring virus–host interactions. To establish a functional hiPSC-LO, we cultured hiPSC-derived endodermal, mesenchymal, and endothelial cells with a chemically defined medium in a three-dimensional microwell culture system. Based on cell-cell interactions, these cells could organize themselves and gradually differentiate into a functional organoid, which exhibited stronger hepatic functions than hiPSC derived hepatic like cell (HLC). Moreover, the functional LO demonstrated more susceptibility to HBV infection than hiPSC-HLC, and could maintain HBV propagation and produce infectious virus for a prolonged duration. Furthermore, we found that virus infection could cause hepatic dysfunction of hiPSC-LOs, with down-regulation of hepatic gene expression, induced release of early acute liver failure markers, and altered hepatic ultrastructure. Therefore, our study demonstrated that HBV infection in hiPSC-LOs could recapitulate virus life cycle and virus induced hepatic dysfunction, suggesting that hiPSC-LOs may provide a promising individualized infection model for the development of individualized treatment for hepatitis. Keywords: Liver organoid, hiPSC, Hepatitis B virus, Virus-host interactions |
url |
http://www.sciencedirect.com/science/article/pii/S2352396418303001 |
work_keys_str_mv |
AT yunzhongnie recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells AT yunwenzheng recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells AT keimiyakawa recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells AT soichiromurata recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells AT ranranzhang recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells AT keisukesekine recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells AT yasuharuueno recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells AT takanoritakebe recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells AT takajiwakita recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells AT akihideryo recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells AT hidekitaniguchi recapitulationofhepatitisbvirushostinteractionsinliverorganoidsfromhumaninducedpluripotentstemcells |
_version_ |
1725148882928664576 |
spelling |
doaj-9fbe19a7a9ad4baeb5c9e965f22d7b122020-11-25T01:17:00ZengElsevierEBioMedicine2352-39642018-09-0135114123Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cellsYun-Zhong Nie0Yun-Wen Zheng1Kei Miyakawa2Soichiro Murata3Ran-Ran Zhang4Keisuke Sekine5Yasuharu Ueno6Takanori Takebe7Takaji Wakita8Akihide Ryo9Hideki Taniguchi10Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan; Department of Advanced Gastroenterological Surgical Science and Technology, University of Tsukuba, Tsukuba-shi, Ibaraki 305-8575, Japan; Research Center of Stem Cells and Regenerative Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, China,; Corresponding authors at: Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan,Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanDepartment of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, 162-8640 Tokyo, JapanDepartment of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan,Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan; Advanced Medical Research Center, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan; Corresponding authors at: Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.Therapies against hepatitis B virus (HBV) have improved in recent decades; however, the development of individualized treatments has been limited by the lack of individualized infection models. In this study, we used human induced pluripotent stem cell (hiPSC) to generate a functional liver organoid (LO) that inherited the genetic background of the donor, and evaluated its application in modeling HBV infection and exploring virus–host interactions. To establish a functional hiPSC-LO, we cultured hiPSC-derived endodermal, mesenchymal, and endothelial cells with a chemically defined medium in a three-dimensional microwell culture system. Based on cell-cell interactions, these cells could organize themselves and gradually differentiate into a functional organoid, which exhibited stronger hepatic functions than hiPSC derived hepatic like cell (HLC). Moreover, the functional LO demonstrated more susceptibility to HBV infection than hiPSC-HLC, and could maintain HBV propagation and produce infectious virus for a prolonged duration. Furthermore, we found that virus infection could cause hepatic dysfunction of hiPSC-LOs, with down-regulation of hepatic gene expression, induced release of early acute liver failure markers, and altered hepatic ultrastructure. Therefore, our study demonstrated that HBV infection in hiPSC-LOs could recapitulate virus life cycle and virus induced hepatic dysfunction, suggesting that hiPSC-LOs may provide a promising individualized infection model for the development of individualized treatment for hepatitis. Keywords: Liver organoid, hiPSC, Hepatitis B virus, Virus-host interactionshttp://www.sciencedirect.com/science/article/pii/S2352396418303001 |